Advertisement

PharmacoEconomics & Outcomes News

, Volume 819, Issue 1, pp 4–4 | Cite as

Addressing uncertainty in cost-effectiveness case for lenalidomide

Clinical study
  • 3 Downloads

Reference

  1. Lee D, et al. The Role of Real-World Evidence in UK Reimbursement: Case Study of Lenalidomide in Myelodysplastic Syndrome Deletion 5q. PharmacoEconomics-Open : 14 Dec 2018. Available from: URL: https://doi.org/10.1007/s41669-018-0110-3

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations